Turpaz Industries Ltd · TASE:TRPZ

Turpaz Industries — Investor Presentation (November 2022)

15 slides from Turpaz Industries's investor presentation, November 2022

  1. Slide 1: Investor Presentation November 2022

    INVESTOR PRESENTATION November 2022 1 1

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation was prepared by Turpaz Industries Ltd. (the "Company") for the sole purpose of conveying information regarding the Company and its subsidiaries (together with the Company "Turpaz Group"). This presentation does not constitute, or form part of, an offer to sell, or a soli

  3. Slide 3: 9M YTD 2022 Highlights

    9M YTD 2022 HIGHLIGHTS (M US $) Sales Gross profit Adjusted EBITDA $ 88.1M $ 34.3M $ 20.3M + 53.7% Sales growth +49.0% +42.7% + 14.7% Organic growth Enhanced and Solid balance sheet, 8 acquisitions from expanded global funding availability and IPO (May 21) – acquisitions strategy 5 in 2022 managemen

  4. Slide 4: 9M YTD 2022 Double Digit Growth

    9M YTD 2022 DOUBLE DIGIT GROWTH – Sales (M US $) Adj. EBITDA** (M US $) 88.1 20.3 42.7% 53.7% 57.3 14.2 34.9 14.7% 9.1 22.9 Organic 5.0 Growth *YTD 9/19 *YTD 9/20 YTD 9/21 YTD 9/22 *YTD 9/19 *YTD 9/20 YTD 9/21 YTD 9/22 4 (*) based on the company's internal reporting (**) Adj EBITDA - earnings before

  5. Slide 5: Sales Breakdown by Territory

    SALES BREAKDOWN BY TERRITORY Europe In M US $ YTD 9/22 – 42.0 YTD 9/21– 20.2 Q3 22 – 14.9 Q3 21 – 7.2 Asia & ROW YTD 9/22 - 8.3 North - YTD 9/21 - 6.2 America Q3 22 – 2.0 Q3 21 – 1.4 YTD 9/22 – 15.5 YTD 9/21 – 17.3 Q3 22 – 6.5 Q3 21 – 4.8 Middle East YTD 9/22 – 22.2 YTD 9/21 – 13.6 Q3 22 – 6.9 Q3 21

  6. Slide 6: Q3 2022 Turpaz – Consolidated

    Q3 2022 TURPAZ – CONSOLIDATED In M US $ / % Q3 2021 Q3 2022 Sales 17.8 30.3 7.2 12.0 Gross profit 40.7% 39.4% Operating profit 3.4 5 19.2% 16.5% (*) Adj. EBITDA 4.4 7.0 (*) Decrease in operating margin due to: (1) Amortization of intangible assets (2) Option share-based payment (3) Recruitment of ma

  7. Slide 7: Q3 2022 Fragrances

    Q3 2022 FRAGRANCES Q3 2021 Q3 2022 In M US $ / % Sales 5.1 6.7 Operating profit 1.9 2.1 37.1% 31.8% Organic growth +13.8% Highlights Strong organic growth LORI profitability is lower than segment profitably. LORI has begun a program to improve its operational efficiency. Improved profitability is ex

  8. Slide 8: Q3 2022 Taste

    Q3 2022 TASTE In M US $ / % Q3 2021 Q3 2022 Sales 5.1 15.1 0.2 2.2 Operating profit 4.8% 14.3% Organic growth +32.8% Highlights Strong organic growth Profitably increased due to acquired companies' profitability and improvement of SDA’s product lines & operational efficiency. 8

  9. Slide 9: Q3 2022 Pharma Intermediates

    Q3 2022 P PHARMA INTERMEDIATES In M US $ / % Q3 2021 Q3 2022 Sales 6.0 5.3 2.0 1.4 Operating profit 33.2% 25.8% Organic growth -4.7% Highlights Profitability mainly affected by Euro USD impacts. 9

  10. Slide 10: Q3 2022 Specialty Ingredients

    Q3 2022 S SPECIALYY INGREDIENTS In M US $ / % Q3 2021 Q3 2022 Sales 1.6 3.2 0.5 0.9 Operating profit 32.6% 29.3% Organic growth +111.8% Highlights Profitability mainly affected by strong organic growth. 10

  11. Slide 11: P&L – Significant Growth

    P&L – SIGNIFICANT K US $ 2021 Q3 2021 Q3 2022 YTD 9/2021 YTD 9/2022 Revenues 85,334 17,839 30,346 57,283 88,056 GROWTH Gross Profit 34,728 7,256 11,950 23,036 34,314 GP% 40.7% 40.7% 39.4% 40.2% 39.0% R&D Expenses 1,949 432 827 1,321 2,329 Sales & Marketing 6,274 1,143 2,496 3,831 7,010 expenses Mana

  12. Slide 12: Balance Sheet

    K US $ 30/9/2021 30/9/2022 BALANCE Assets SHEET Current Assets 99,110 92,944 Non-Current Assets 34,834 93,124 Total Assets 133,944 186,068 Liabilities & Equity Current Liabilities 24,119 35,140 Non-Current Liabilities 25,821 60,061 Equity 84,004 90,867 Total Liabilities and Equity 133,944 186,068 Ra

  13. Slide 13: Proven Track Record of Acquisitions

    PROVEN TRACK RECORD OF ACQUISITIONS 2020 2021 2022 Acquisitions global pipeline Florasynth SDA Lori 100% (Tastes) 49% (Tastes) 100% (Fragrances) P S Balirom 60% + option SDA FIT 60% + option 40% (Tastes) 51% (Tastes) 40% (Savory) Pentaor 100% (Tastes) WFF Pilpel & 60% + option 40% Galilee Herbs Klab

  14. Slide 14: Multinational Company

    Multinational Company Latvia 1 site – Fragrance Belgium Poland Sales 1 site – F&F Production 1 site - Savory Sales R&D Sales Production Production Romania* R&D R&D 1 sites –Savory Sales USA Production R&D 2 site – F&F Sales Production R&D Israel Vietnam 7 sites – F&F, Savory, pharma 1 site – F&F & s

  15. Slide 15: Thank You

    )TURPAZ Fragrances & Flavors

Turpaz Industries — Investor Presentation (November 2022) on 6ix